177Lu-TATE-RGD
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for 177Lu-TATE-RGD, covering 2024-10-15 to 2024-10-15. Get the full timeline:
Most recent: Clinical Trial Update: 177Lu-TATE-RGD in Patients With SSTR2 and Integrin αVβ3 Positive Tumors [EARLY_Phase 1]